Machine Learning Maps and Discovers Clinical Endpoints in Pompe Disease Using Real-World Data
In the largest machine learning study of Pompe disease to date, Volv Global demonstrates that clinician-defined endpoints can be tracked and novel disease features discovered in US claims data across 3,549 patients ÉPALINGES, Switzerland, May 31, 2026 /PRNewswire-PRWeb/ -- In brief...
In the largest machine learning study of Pompe disease to date, Volv Global demonstrates that clinician-defined endpoints can be tracked and novel disease features discovered in US claims data across 3,549 patients ÉPALINGES, Switzerland, May 31, 2026 /PRNewswire-PRWeb/ -- In brief...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.